Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Tuberculosis

Free Subscription 08.09.2025 1 Antimicrob Agents Chemother 2 Clin Infect Dis 6 Int J Tuberc Lung Dis 1 J Bacteriol 1 J Infect 1 J Infect Dis 1 Lancet 5 PLoS One 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. RESENDIZ-GALVAN JE, Arora PR, Lokhande RV, Udwadia ZF, et al
   Evaluation of cycloserine dose regimens in an Indian cohort with multidrug-resistant tuberculosis: a population pharmacokinetic analysis.
   Antimicrob Agents Chemother. 2025 Sep 2:e0010125. doi: 10.1128/aac.00101.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

2. PEREZ-RECIO S, Grijota-Camino MD, Guardiola J, Juanola X, et al
   Prevention of Tuberculosis in Patients Treated With Biological Therapies: Twenty Years' Experience in a Specialised Tuberculosis Clinic in a Low-prevalence Country.
   Clin Infect Dis. 2025 Sep 5:ciaf491. doi: 10.1093.
   PubMed         Abstract available
   
   
3. ARRIAGA MB, Amorim G, Figueiredo MC, Staats C, et al
   Body Mass Index and Incident Tuberculosis in Close Tuberculosis Contacts.
   Clin Infect Dis. 2025 Sep 3:ciaf475. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Int J Tuberc Lung Dis

4. MALIK AA, Martinez L
   Achieving optimal uptake of TB preventive treatment for rifampin-resistant and/or multidrug-resistant TB.
   Int J Tuberc Lung Dis. 2025;29:387-389.
   PubMed         Abstract available
   
   
5. ZHOU M, Yang Z, Ni Z, Xiao J, et al
   Clinical outcomes for drug-resistant TB patients after adjunctive resectional lung surgery.
   Int J Tuberc Lung Dis. 2025;29:397-403.
   PubMed         Abstract available
   
   
6. PRASETYO YA, Thanasilp S, Preechawong S
   The development of an adherence to treatment scale for pulmonary TB.
   Int J Tuberc Lung Dis. 2025;29:410-415.
   PubMed         Abstract available
   
   
7. NGIAM JN, Koh MCY, D'Ambrosio L, Goletti D, et al
   Artificial intelligence for TB education and counselling: a modified Delphi consensus.
   Int J Tuberc Lung Dis. 2025;29:390-396.
   PubMed         Abstract available
   
   
8. SCHRAUFNAGEL AM, Crowder R, Wambi P, Nakasendwa S, et al
   Use of a digital adherence technology to support TB treatment among adolescents.
   Int J Tuberc Lung Dis. 2025;29:404-409.
   PubMed         Abstract available
   
   
9. DAS M, Kalra A, ThekkePurakkal AS, Showket T, et al
   Implementing TB preventive therapy: lessons from a large-scale initiative in India.
   Int J Tuberc Lung Dis. 2025;29:416-421.
   PubMed         Abstract available
   
   

   
   J Bacteriol

10. VARSHNEY A, Alumasa JN, Miller A, Keiler KC, et al
    A trans-translation inhibitor that targets ribosomal protein bL12 kills Mycobacterium tuberculosis.
    J Bacteriol. 2025 Sep 3:e0023625. doi: 10.1128/jb.00236.
    PubMed         Abstract available
    
    

    
    J Infect

11. TIAN N, Li P, Ju D, Lai S, et al
    The real-world performance of a novel interferon gamma release assay based on fluorescence immunochromatography in detecting Mycobacterium tuberculosis infection in South China.
    J Infect. 2025;91:106605.
    PubMed        
    
    

    
    J Infect Dis

12. SARTI E, Dolle C, Wolfensberger R, Kusejko K, et al
    c-Myc inhibits macrophage antimycobacterial response in Mycobacterium tuberculosis infection.
    J Infect Dis. 2025 Aug 30:jiaf456. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Lancet

13. DROBNIEWSKI F, Kon OM, Gonzalo X, Ashmi M, et al
    Why are we failing to rapidly diagnose tuberculosis in the UK?
    Lancet. 2025;406:908-909.
    PubMed        
    
    

    
    PLoS One

14. GARCIA-ZAMALLOA A, Arnay R, Castilla-Rodriguez I, Mar J, et al
    Machine learning for predicting the diagnosis of tuberculous versus malignant pleural effusion: External validation and accuracy in two different settings.
    PLoS One. 2025;20:e0329668.
    PubMed         Abstract available
    
    
15. JARLSBERG LG, Kedia K, Wendler J, Wright AT, et al
    Correction: Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region.
    PLoS One. 2025;20:e0331721.
    PubMed         Abstract available
    
    
16. ESMAEL A, Mihret A, Abebe T, Mussa D, et al
    Activation and proliferation profiles of M.tuberculosis specific dual functional CD4+T cells from smear negative pulmonary TB patients.
    PLoS One. 2025;20:e0327243.
    PubMed         Abstract available
    
    
17. WEBER SF, Wolf R, Manten K, Thangakunam B, et al
    Lung and abdominal ultrasound accuracy for tuberculosis: An Indian prospective cohort study.
    PLoS One. 2025;20:e0329670.
    PubMed         Abstract available
    
    
18. YISMAW L, Zewotir T, Muluneh EK, Getnet F, et al
    Burden of tuberculosis in Eastern Africa region from 1990-2021: A systematic analysis for the Global Burden of Disease 2021 Study.
    PLoS One. 2025;20:e0331035.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

19. KOLESKE B, Rajagopalan S, Schill C, Lun S, et al
    Loss of the ESX-5 secretion locus in Mycobacterium tuberculosis reshapes the mycomembrane and enhances ESX-1 substrate secretion.
    Proc Natl Acad Sci U S A. 2025;122:e2509997122.
    PubMed         Abstract available
    
    
20. WANG ER, Cho K, Harrison GA, Smelyansky SR, et al
    Metabolic rewiring of isoniazid sensitivity in Mycobacterium tuberculosis.
    Proc Natl Acad Sci U S A. 2025;122:e2421336122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.